Cosentyx snrdy 300MG dose-2PENML

Ended Awarded

Contract number
SPE2DB25FX41C
Awardee
Awarding agency
Obligated
$37,785

Award facts

Contract value 100% obligated
$37,785.41 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $37,785.41 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2 pen/mL formulation. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, is structured as a firm fixed price delivery order with no set-aside designation. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.

AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across the Department of Defense and veteran healthcare systems. The company's selection for this order reflects its capability to meet federal procurement requirements through open competition, consistent with its extensive portfolio of delivery orders from DLA covering a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies. The DLA Troop Support Medical contract vehicle enables the vendor to supply pharmaceutical commodities to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.

Quick answers

Who was awarded contract SPE2DB25FX41C?

SPE2DB25FX41C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.

How much is contract SPE2DB25FX41C worth?

The government has obligated $37,785 on SPE2DB25FX41C.

Is contract SPE2DB25FX41C an order under another contract?

Yes. SPE2DB25FX41C is a delivery order under SPE2DB20D2200, an indefinite delivery contract.

Was contract SPE2DB25FX41C competed?

The extent of competition for SPE2DB25FX41C was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award